Health and Wellness

World Health Organization Approves Second-Ever Malaria Vaccine To Help ‘Close The Huge Supply-And-Demand Gap’

<p>The World Health Organization &lpar;WHO&rpar; has officially approved the world&&num;8217&semi;s second-ever malaria vaccine&period; It was developed at the University of Oxford and will cost between &dollar;2 and &dollar;4 USD per dose&period;<&sol;p>&NewLine;<h3 style&equals;"text-align&colon; center&semi;">The New Vaccine Will Help &&num;8220&semi;Protect More Children Faster&&num;8221&semi;<&sol;h3>&NewLine;<p>The WHO announced the news through a <a href&equals;"https&colon;&sol;&sol;www&period;who&period;int&sol;news&sol;item&sol;02-10-2023-who-recommends-r21-matrix-m-vaccine-for-malaria-prevention-in-updated-advice-on-immunization" target&equals;"&lowbar;blank" rel&equals;"noopener">statement<&sol;a> on Monday &lpar;Oct&period; 2&rpar;&period; <strong>Dr&period; Tedros Adhanom Ghebreyesus<&sol;strong> — the organization&&num;8217&semi;s director-general — declared he used to &&num;8220&semi;dream&&num;8221&semi; of this moment&period;<&sol;p>&NewLine;<blockquote><p>&&num;8220&semi;As a malaria researcher&comma; I used to dream of the day we would have a safe and effective vaccine against malaria&period; Now we have two&period;&&num;8221&semi;<&sol;p><&sol;blockquote>&NewLine;<p>He added&comma; <strong><em>&&num;8220&semi;This second vaccine is a vital additional tool to protect more children faster&comma; and to bring us closer to our vision of a malaria-free future&period;&&num;8221&semi;<&sol;em><&sol;strong><&sol;p>&NewLine;<p>The WHO&&num;8217&semi;s Regional Director for Africa&comma; <strong>Dr&period; Matshidiso Moeti<&sol;strong>&comma; further highlighted this sentiment&period; He noted that the two WHO-approved vaccines &&num;8220&semi;can help bolster malaria prevention and control efforts&&num;8221&semi; in Africa&period;<&sol;p>&NewLine;<blockquote><p>&&num;8220&semi;This second vaccine holds real potential to close the huge demand-and-supply gap&period; Delivered to scale and rolled out widely&comma; the two vaccines can help bolster malaria prevention and control efforts and save hundreds of thousands of young lives in Africa from this deadly disease&period;&&num;8221&semi;<&sol;p><&sol;blockquote>&NewLine;<p>For context&comma; the WHO notes that malaria &&num;8220&semi;places a particularly high burden on children in the African Region&comma; where nearly half a million children die from the disease each year&period;&&num;8221&semi;<&sol;p>&NewLine;<p>However&comma; <a href&equals;"https&colon;&sol;&sol;apnews&period;com&sol;article&sol;malaria-vaccine-oxford-who-f2dbc55cb7f92f82af52f7898a8260d0" target&equals;"&lowbar;blank" rel&equals;"noopener">AP News<&sol;a> reports that <strong>John Johnson<&sol;strong> of Doctors Without Borders points out that the vaccine isn&&num;8217&semi;t a sure-fire solution&period;<&sol;p>&NewLine;<blockquote><p>&&num;8220&semi;This is one more tool we will now have&comma; but it’s not going to replace bed nets and spraying insecticides&period; This is not the vaccine that&&num;8217&semi;s going to stop malaria&period;&&num;8221&semi;<&sol;p><&sol;blockquote>&NewLine;<p><a href&equals;"https&colon;&sol;&sol;www&period;reuters&period;com&sol;business&sol;healthcare-pharmaceuticals&sol;who-recommends-malaria-vaccine-roll-out-early-2024-some-african-countries-2023-10-02&sol;" target&equals;"&lowbar;blank" rel&equals;"noopener">Reuters<&sol;a> notes that the vaccine was developed at the University of Oxford&comma; and it will become available by mid-2024&period;<&sol;p>&NewLine;<p><amp-twitter data-tweetid&equals;"1708925427480154441" layout&equals;"responsive" width&equals;"600" height&equals;"480"><&sol;amp-twitter><&sol;p>&NewLine;<h3 style&equals;"text-align&colon; center&semi;">The WHO Approved The First Malaria Vaccine In 2021<&sol;h3>&NewLine;<p>This noteworthy development comes nearly two years after the WHO officially endorsed the first-ever malaria vaccine&period;<&sol;p>&NewLine;<p><a href&equals;"https&colon;&sol;&sol;apnews&period;com&sol;article&sol;malaria-vaccine-dcb917ea3fbd090484bfe6750d4ea58c" target&equals;"&lowbar;blank" rel&equals;"noopener">AP News<&sol;a> reports the &&num;8220&semi;historic&&num;8221&semi; decision came as a result of researchers tracking more than 800&comma;000 Ghanaian&comma; Kenyan&comma; and Malawian children who received the vaccine since 2019&period;<&sol;p>&NewLine;<p>The vaccine&comma; Mosquirix&comma; was initially conceived in 1987 and boasts a 30&percnt; effectiveness rate&period; Nonetheless&comma; <strong>Dr&period; Julian Rayner<&sol;strong> of the Cambridge Institute for Medical Research said the &&num;8220&semi;imperfect vaccine&&num;8221&semi; was a &&num;8220&semi;huge step forward&period;&&num;8221&semi;<&sol;p>&NewLine;<p>In the WHO&&num;8217&semi;s recent statement on a second&comma; cheaper vaccine being approved&comma; the organization declared&comma; <strong><em>&&num;8220&semi;Both vaccines are shown to be safe and effective in preventing malaria in children and&comma; when implemented broadly&comma; are expected to have high public health impact&period;&&num;8221&semi;<&sol;em><&sol;strong><&sol;p>&NewLine;<h5 style&equals;"text-align&colon; center&semi;">RELATED&colon; <a href&equals;"https&colon;&sol;&sol;dev&period;theshaderoom&period;com&sol;at-least-74-perish-building-fire-south-africa-johannesburg&sol;" target&equals;"&lowbar;blank" rel&equals;"noopener">At Least 74 Perish During Devastating Building Fire In South Africa<&sol;a><&sol;h5>&NewLine; <div class&equals;"wpra-reactions-wrap wpra-plugin-container" style&equals;"justify-content&colon; center&semi;&semi;"> <div class&equals;"wpra-reactions-container" data-ver&equals;"1&period;3&period;10" data-post&lowbar;id&equals;"146369" data-show&lowbar;count&equals;"true" data-enable&lowbar;share&equals;"onclick" data-behavior&equals;"regular" data-animation&equals;"true" data-share&lowbar;url&equals;"https&colon;&sol;&sol;dev&period;theshaderoom&period;com&sol;world-health-organization-approves-second-ever-malaria&sol;" data-secure&equals;"b58d235200"> <div class&equals;"wpra-call-to-action" style&equals;"color&colon; &num;000000&semi;font-size&colon; 25px&semi;font-weight&colon; 600&semi;">What Do You Think Roomies&quest;<&sol;div> <div class&equals;"wpra-reactions wpra-static-emojis size-medium" style&equals;"border-color&colon; &num;ffffff&semi;border-width&colon; 0px&semi;border-radius&colon; 50px&semi;border-style&colon; solid&semi;background&colon; &num;ffffff&semi;">&Tab;&Tab;&Tab;&Tab;&Tab;<div class&equals;"emoji-8 wpra-reaction wpra-pad-fix" data-count&equals;"" data-emoji&lowbar;id&equals;"8"> <div class&equals;"wpra-plus-one">&plus;1<&sol;div>&Tab; <div style&equals;"background-color&colon; &num;ff0015" class&equals;"wpra-arrow-badge arrow-bottom-left hide-count"> <span style&equals;"border-top-color&colon; &num;ff0015" class&equals;"tail"><&sol;span> <span style&equals;"color&colon; &num;ffffff" class&equals;"count-num">0<&sol;span> <&sol;div>&Tab;<&sol;div><div class&equals;"emoji-10 wpra-reaction wpra-pad-fix" data-count&equals;"" data-emoji&lowbar;id&equals;"10"> <div class&equals;"wpra-plus-one">&plus;1<&sol;div>&Tab; <div style&equals;"background-color&colon; &num;ff0015" class&equals;"wpra-arrow-badge arrow-bottom-left hide-count"> <span style&equals;"border-top-color&colon; &num;ff0015" class&equals;"tail"><&sol;span> <span style&equals;"color&colon; &num;ffffff" class&equals;"count-num">0<&sol;span> <&sol;div>&Tab;<&sol;div><div class&equals;"emoji-4 wpra-reaction" data-count&equals;"" data-emoji&lowbar;id&equals;"4"> <div class&equals;"wpra-plus-one">&plus;1<&sol;div>&Tab; <div style&equals;"background-color&colon; &num;ff0015" class&equals;"wpra-arrow-badge arrow-bottom-left hide-count"> <span style&equals;"border-top-color&colon; &num;ff0015" class&equals;"tail"><&sol;span> <span style&equals;"color&colon; &num;ffffff" class&equals;"count-num">0<&sol;span> <&sol;div>&Tab;<&sol;div><div class&equals;"emoji-5 wpra-reaction" data-count&equals;"" data-emoji&lowbar;id&equals;"5"> <div class&equals;"wpra-plus-one">&plus;1<&sol;div>&Tab; <div style&equals;"background-color&colon; &num;ff0015" class&equals;"wpra-arrow-badge arrow-bottom-left hide-count"> <span style&equals;"border-top-color&colon; &num;ff0015" class&equals;"tail"><&sol;span> <span style&equals;"color&colon; &num;ffffff" class&equals;"count-num">0<&sol;span> <&sol;div>&Tab;<&sol;div><div class&equals;"emoji-2 wpra-reaction" data-count&equals;"" data-emoji&lowbar;id&equals;"2"> <div class&equals;"wpra-plus-one">&plus;1<&sol;div>&Tab; <div style&equals;"background-color&colon; &num;ff0015" class&equals;"wpra-arrow-badge arrow-bottom-left hide-count"> <span style&equals;"border-top-color&colon; &num;ff0015" class&equals;"tail"><&sol;span> <span style&equals;"color&colon; &num;ffffff" class&equals;"count-num">0<&sol;span> <&sol;div>&Tab;<&sol;div><div class&equals;"emoji-7 wpra-reaction" data-count&equals;"" data-emoji&lowbar;id&equals;"7"> <div class&equals;"wpra-plus-one">&plus;1<&sol;div>&Tab; <div style&equals;"background-color&colon; &num;ff0015" class&equals;"wpra-arrow-badge arrow-bottom-left hide-count"> <span style&equals;"border-top-color&colon; &num;ff0015" class&equals;"tail"><&sol;span> <span style&equals;"color&colon; &num;ffffff" class&equals;"count-num">0<&sol;span> <&sol;div>&Tab;<&sol;div><div class&equals;"emoji-12 wpra-reaction" data-count&equals;"" data-emoji&lowbar;id&equals;"12"> <div class&equals;"wpra-plus-one">&plus;1<&sol;div>&Tab; <div style&equals;"background-color&colon; &num;ff0015" class&equals;"wpra-arrow-badge arrow-bottom-left hide-count"> <span style&equals;"border-top-color&colon; &num;ff0015" class&equals;"tail"><&sol;span> <span style&equals;"color&colon; &num;ffffff" class&equals;"count-num">0<&sol;span> <&sol;div>&Tab;<&sol;div> <&sol;div> <div class&equals;"wpra-share-wrap wpra-share-buttons-bordered" style&equals;"">&Tab;&Tab;&Tab;&Tab; <&sol;div> <&excl;-- end of share buttons -->&Tab;&Tab;&Tab; <&sol;div> <&excl;-- end of reactions container --> <&sol;div> <&excl;-- end of reactions wrap -->&Tab;&Tab;

Nick Fenley

x